Improvement of Oxidative and Metabolic Parameters by Cellfood Administration in Patients Affected by Neurodegenerative Diseases on Chelation Treatment

<table>Oxidized LDL (oxLDL)/LDL ratios, oxLDL/LDL ratios, total cholesterol (TC)/HDL ratios, and LDL/HDL ratios calculated from the levels of subjects unaffected (controls) or patients affected by neurodegenerative diseases (ND). All subjects’ values were determined before the beginning (basal values) and after three months of treatment with Cellfood or other antioxidants (see text).</table>

BioMed Research International

fig5

Figure 5

Figure 5: Improvement of Oxidative and Metabolic Parameters by Cellfood Administration in Patients Affected by Neurodegenerative Diseases on Chelation Treatment 

Figure 5 | Improvement of Oxidative and Metabolic Parameters by Cellfood Administration in Patients Affected by Neurodegenerative Diseases on Chelation Treatment 